Publication
Global management of drug-drug interaction in patients with prostate cancer: international survey by Meet-URO group and ONCOassist.
Anna Amela Valsecchi, Michele Maffezzoli, Maria Concetta Cursano, Mattia Di Civita, Fiorenza Santamaria, Stefania Kingspergher, Elisa Zanardi, Giuseppe Procopio, Suleka Ashok, Lakshmi Ramachandran, Renita George, Kevin Bambury, Richard Bambury, Eoin O'Carroll, Giuseppe Luigi Banna, Massimo Di Maio, Daniele Santini
- Source
- PubMed
- Retrieved
- Sep 18, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260918-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND: Patients with prostate cancer (PC) frequently receive multiple medications for comorbidities, increasing the risk of drug-drug interactions (DDIs). Despite guidelines highlighting DDI relevance, data on real-world management are limited. This international survey aimed to characterize…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Prostate Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available